All In Biotech

Drug Trial Radar · NCT01350934

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

A 6-Month, Randomized, Open-Label, Active-Comparator Controlled, Parallel-Group Study With a 6-Month Extension to Evaluate the Safety and Efficacy of Alendronate Sodium 70 mg/Vitamin D3 5600 I.U. Combination Tablets Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China

Last checked: Nov 20, 2026Latest source record: Jun 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 219 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

219

Actual

Start

Jun 19, 2011

Primary completion

Jan 10, 2013

Study completion Jan 10, 2013

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
May 10, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 56 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate whether the once weekly administration of the combination tablet alendronate/vitamin D3 (FOSAMAX PLUS) will increase lumbar spine bone mineral density (BMD) more than the daily use of calcitriol.

Conditions

  • Osteoporosis, Postmenopausal

Interventions

  • alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus)Drug

    one combination tablet once weekly

  • CalcitriolDrug

    0.25 μg once daily orally

  • Calcium 500 mgDietary supplement

    one 500 mg tablet once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Base Study: Percentage Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Month 6Time frame: Baseline and Month 6
  2. Extension Study: Percentage Change From Baseline in Lumbar Spine BMD at Month 12Time frame: Baseline and Month 12

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.